|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-9-1
|
|
pubmed:abstractText |
Antithymocyte globulin or human Jurkat T-cell-line-derived antilymphocyte globulin is used in allogeneic stem cell transplantation to induce in vivo T-cell depletion to facilitate engraftment and lower graft-versus-host disease. In vitro studies suggest that antithymocyte globulin, besides causing T-cell depletion, has strong anti-myeloma activity.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
pubmed-author:AlegreAdriánA,
pubmed-author:AtanackovicDjordjeD,
pubmed-author:AyukFrancisF,
pubmed-author:KrögerNicolausN,
pubmed-author:LahuertaJuan-JoséJJ,
pubmed-author:MartinoRodrigoR,
pubmed-author:NaglerArnonA,
pubmed-author:Perez-SimonJosé AJA,
pubmed-author:San MiguelJesús FJF,
pubmed-author:SayerHerbert GottfriedHG,
pubmed-author:SchwerdtfegerRainerR,
pubmed-author:ShimoniAvichaiA,
pubmed-author:SuredaAnnaA,
pubmed-author:WolschkeChristineC,
pubmed-author:ZabelinaTatjanaT,
pubmed-author:ZanderAxel RAR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1343-50
|
|
pubmed:meshHeading |
pubmed-meshheading:18641030-Adult,
pubmed-meshheading:18641030-Aged,
pubmed-meshheading:18641030-Antilymphocyte Serum,
pubmed-meshheading:18641030-Disease-Free Survival,
pubmed-meshheading:18641030-Female,
pubmed-meshheading:18641030-Graft vs Host Disease,
pubmed-meshheading:18641030-Humans,
pubmed-meshheading:18641030-Jurkat Cells,
pubmed-meshheading:18641030-Male,
pubmed-meshheading:18641030-Middle Aged,
pubmed-meshheading:18641030-Multiple Myeloma,
pubmed-meshheading:18641030-Neoplasm Staging,
pubmed-meshheading:18641030-Recurrence,
pubmed-meshheading:18641030-Siblings,
pubmed-meshheading:18641030-Stem Cell Transplantation,
pubmed-meshheading:18641030-Survival Rate,
pubmed-meshheading:18641030-Transplantation, Homologous
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
|
|
pubmed:affiliation |
Dept of Stem cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.
|
|
pubmed:publicationType |
Journal Article
|
